Rapport Therapeutics is a precision medicine company focused on treating neurological disorders by targeting disease-driving neurocircuits using receptor-associated proteins (RAPs). This approach aims to overcome the limitations of current neuromedicines, offering more effective and manageable treatments. Led by an experienced team with strong records in neuroscience and drug discovery, Rapport was founded by Third Rock Ventures and Johnson & Johnson Innovation-JJDC, Inc., and is headquartered in San Diego and Boston.
Rapport Therapeutics is seeking a Senior Manager of Regulatory Affairs to lead the regulatory execution for global Phase 3 clinical trials of RAP-219. This role involves ensuring successful interactions with regulatory authorities, coordinating submissions, and staying updated with evolving guidelines. The ideal candidate is a detail-oriented professional with experience in the pharmaceutical or biotechnology industry. Rapport values scientific innovation, teamwork, and employee growth.
Rapport Therapeutics is a precision medicine company focused on treating neurological disorders by targeting disease-driving neurocircuits using receptor-associated proteins (RAPs). This approach aims to overcome the limitations of current neuromedicines, offering more effective and manageable treatments. Led by an experienced team with strong records in neuroscience and drug discovery, Rapport was founded by Third Rock Ventures and Johnson & Johnson Innovation-JJDC, Inc., and is headquartered in San Diego and Boston.
Formation Bio